Estate Planners Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Estate Planners Group's BMY Position: Q1 2026 in Review
Estate Planners Group increased its Bristol-Myers Squibb (BMY) stake by 1.1% in Q1 2026, buying an estimated $3.85K and bringing the position to 6,174 shares worth $374K. The position accounts for 0.18% of the portfolio, ranked #49.
Estate Planners Group first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Estate Planners Group held 6,174 shares of Bristol-Myers Squibb worth $374K as of Q1 2026.
- Estate Planners Group bought 66 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.85K.
- Bristol-Myers Squibb made up 0.18% of Estate Planners Group's portfolio in Q1 2026, its #49 holding.
- Estate Planners Group first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Estate Planners Group's 13F filing for Q1 2026, filed 11 May 2026.